The store will not work correctly when cookies are disabled.
(1S,4S)-5-(6-chloropyridazin-3-yl)-2,2-dimethyl-5-aza-2-azoniabicyclo[2.2.1]heptane iodide
ID: ALA1083279
PubChem CID: 10861492
Max Phase: Preclinical
Molecular Formula: C11H16ClIN4
Molecular Weight: 239.73
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: C[N+]1(C)C[C@@H]2C[C@H]1CN2c1ccc(Cl)nn1.[I-]
Standard InChI: InChI=1S/C11H16ClN4.HI/c1-16(2)7-8-5-9(16)6-15(8)11-4-3-10(12)13-14-11;/h3-4,8-9H,5-7H2,1-2H3;1H/q+1;/p-1/t8-,9-;/m0./s1
Standard InChI Key: BDQRCADDNGPCNL-OZZZDHQUSA-M
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
-5.1563 -4.4063 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
-4.5807 -4.6806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5807 -5.5055 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8699 -5.9157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1548 -5.5055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1548 -4.6806 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8699 -4.2619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2730 -5.1186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4440 -4.2703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7308 -4.6886 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0151 -4.2763 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0107 -3.4543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7311 -3.0390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4424 -3.4507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2951 -3.0395 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-3.8699 -3.4370 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.8699 -6.7405 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.3908 -5.2856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8017 -6.3082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 7 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
4 8 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
6 9 1 0
12 15 1 0
7 16 1 6
4 17 1 6
3 18 1 0
2 3 1 0
3 19 1 0
M CHG 2 1 -1 3 1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 239.73 | Molecular Weight (Monoisotopic): 239.1058 | AlogP: 1.17 | #Rotatable Bonds: 1 |
Polar Surface Area: 29.02 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.96 | CX LogP: -3.00 | CX LogD: -3.00 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.69 | Np Likeness Score: -0.78 |
References
1. Li T, Bunnelle WH, Ryther KB, Anderson DJ, Malysz J, Helfrich R, Grønlien JH, Håkerud M, Peters D, Schrimpf MR, Gopalakrishnan M, Ji J.. (2010) Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligands., 20 (12): [PMID:20472430] [10.1016/j.bmcl.2010.04.105] |